Abstract
Under physiological conditions, CD8+ T cells need to recognize low numbers of antigenic pMHC class I complexes in the presence of a surplus of non-stimulatory, self pMHC class I on the surface of the APC. Non-stimulatory pMHC have been shown to enhance CD8+ T cell responses to low amounts of antigenic pMHC, in a phenomenon called co-agonism, but the physiological significance and molecular mechanism of this phenomenon are still poorly understood. Our data show that co-agonist pMHC class I complexes recruit CD8-bound Lck to the immune synapse to modulate CD8+ T cell signaling pathways, resulting in enhanced CD8+ T cell effector functions and proliferation, both in vitro and in vivo. Moreover, co-agonism can boost T cell proliferation through an extrinsic mechanism, with co-agonism primed CD8+ T cells enhancing Akt pathway activation and proliferation in neighboring CD8+ T cells primed with low amounts of antigen.
Original language | English (US) |
---|---|
Article number | 721722 |
Journal | Frontiers in immunology |
Volume | 12 |
DOIs | |
State | Published - Oct 11 2021 |
Externally published | Yes |
Keywords
- AKT pathway
- co-agonism
- Lck
- non-stimulatory peptide MHC
- T cell effector functions
- T cell receptor
- T cell signaling
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology